BioVox: the global network for Belgian life sciences turns five and launches a new website!
For the past five years, BioVox has provided a growing international community of readers with insights into the Belgian life sciences ecosystem. Our free monthly newsletter features exclusive content on the latest breakthroughs and industry developments. After half a decade of success, BioVox has now launched a fresh new website featuring Onno Van De Stolpe sharing his insights on the Belgian life sciences ecosystem.
BioVox is the brainchild of Ann Van Gysel, founder of Turnstone Communications. An established consultancy agency based in Belgium, Turnstone has provided communications, marketing and strategic support to companies and organizations in the life sciences industry for over 10 years.
Today, the BioVox community is a diverse international network that spans industry, academia and finance. With a local focus and global reach, BioVox highlights the importance of Belgium’s world-class life sciences ecosystem to a truly international audience: about 30% of readers are based in the US; 30% in Belgium; 30% in the rest of Europe; as well as 10% in Asia and beyond (see infographic).
Quality content for free
The free monthly content on BioVox is made possible through the support of Turnstone Communications and its clients, as well as sponsored articles from other organizations and companies. You can read about BioVox’s dedicated supporters on the showcase pages of the new website, or visit Turnstone’s website if you would like to know more about the company’s communication, marketing and business services.
Every month, the free BioVox newsletter features exclusive insights into the latest breakthroughs and industry developments. The latest articles include:
• An interview with Onno van de Stolpe, CEO of Galapagos, where he shares his thoughts on the future of Belgian biotech
• An article featuring Sjaak Vink from TheSocialMedwork, a company giving international patients access to lifesaving drugs
• Insights into the latest developments in Belgian COVID-19 clinical trials with Bart Lambrecht
• An overview of cell therapy opportunities and challenges, guest-authored by V-Bio Ventures
Interested in connecting with the international BioVox community? Do you have an upcoming event or news to share? BioVox would love to hear from you!
Enjoy the new website!
